English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907437      Online Users : 954
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/1256


    Title: Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities
    Authors: Mahindroo, N;Huang, CF;Peng, YH;Wang, CC;Liao, CC;Lien, TW;Chittimalla, SK;Huang, WJ;Chai, CH;Prakash, E;Chen, CP;Hsu, TA;Peng, CH;Lu, IL;Lee, LH;Chang, YW;Chen, WC;Chou, YC;Chen, CT;Goparaju, CMV;Chen, YS;Lan, SJ;Yu, MC;Chen, X;Chao, YS;Wu, SY;Hsieh, HP
    Contributors: Division of Biotechnology and Pharmaceutical Research
    Abstract: The synthesis and structure-activity relationship studies of novel indole derivatives as peroxisome proliferator-activated receptor (PPAR) agonists are reported. Indole, a druglike scaffold, was studied as a core skeleton for the acidic head part of PPAR agonists. The structural features (acidic head, substitution on indole, and linker) were optimized first, by keeping benzisoxazole as the tail part, based on binding and functional activity at PPAR gamma protein. The variations in the tail part, by introducing various heteroaromatic ring systems, were then studied. In vitro evaluation led to identification of a novel series of indole compounds with a benzisoxazole tail as potent PPAR agonists with the lead compound 14 (BPR1H036) displaying an excellent pharmacokinetic profile in BALB/c mice and an efficacious glucose lowering activity in KKA(y) mice. Structural biology studies of 14 showed that the indole ring contributes strong hydrophobic interactions with PPAR gamma and could be an important moiety for the binding to the protein.
    Keywords: Chemistry, Medicinal
    Date: 2005-12-29
    Relation: Journal of Medicinal Chemistry. 2005 Dec;48(26):8194-8208.
    Link to: http://dx.doi.org/10.1021/jm0506930
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0022-2623&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000234301800012
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=29744432852
    Appears in Collections:[謝興邦] 期刊論文
    [伍素瑩] 期刊論文
    [徐祖安] 期刊論文
    [趙宇生(2002-2013)] 期刊論文
    [陳新(2002-2015)] 期刊論文
    [陳炯東] 期刊論文

    Files in This Item:

    File Description SizeFormat
    000234301800012.pdf484KbAdobe PDF525View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback